Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
Clin Cancer Res
; 2(6): 963-72, 1996 Jun.
Article
en En
| MEDLINE
| ID: mdl-9816257
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Radioinmunoterapia
/
Radioisótopos de Yodo
/
Neoplasias Meníngeas
/
Anticuerpos Monoclonales
Límite:
Adolescent
/
Adult
/
Aged
/
Animals
/
Child, preschool
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
1996
Tipo del documento:
Article